Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Aronia melanocarpa (black chokeberry) has attracted scientific interest for its potential role in aging prevention, primarily due to its high content of polyphenols and anthocyanins—compounds known for their antioxidant properties. Several preclinical studies have demonstrated that Aronia extracts can reduce oxidative stress and inflammation, both of which are implicated in the aging process and age-related diseases. For example, in vitro and animal studies show that Aronia polyphenols can scavenge free radicals and modulate pathways involved in cellular aging, such as the NF-κB and Nrf2 pathways. Some human studies have reported improvements in markers of oxidative stress and endothelial function after Aronia supplementation, but these are generally small, short-term trials and do not directly assess clinical endpoints related to aging or longevity.

While the antioxidant and anti-inflammatory effects are well-documented in laboratory settings, robust clinical evidence demonstrating that Aronia can prevent or slow aging in humans is lacking. There is currently no long-term, large-scale human research directly linking Aronia consumption to reduced aging or increased lifespan. Therefore, the evidence rating is moderate (2 out of 5), reflecting promising mechanistic and preliminary clinical findings, but insufficient direct evidence for efficacy in aging prevention in humans.

More about Aronia melanocarpa
More about Aging (prevention)

Other ingredients used for Aging (prevention)

Other health conditions supported by Aronia melanocarpa

Products containing Aronia melanocarpa